Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies.

MLA

Biber, Guy, et al. “Targeting the Actin Nucleation Promoting Factor WASp Provides a Therapeutic Approach for Hematopoietic Malignancies.” Nature Communications, vol. 12, no. 1, Sept. 2021, p. 5581. EBSCOhost, https://doi.org/10.1038/s41467-021-25842-7.

APA

Biber, G., Ben-Shmuel, A., Noy, E., Joseph, N., Puthenveetil, A., Reiss, N., Levy, O., Lazar, I., Feiglin, A., Ofran, Y., Kedmi, M., Avigdor, A., Fried, S., & Barda-Saad, M. (2021). Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies. Nature Communications, 12(1), 5581. https://doi.org/10.1038/s41467-021-25842-7

Chicago

Biber, Guy, Aviad Ben-Shmuel, Elad Noy, Noah Joseph, Abhishek Puthenveetil, Neria Reiss, Omer Levy, et al. 2021. “Targeting the Actin Nucleation Promoting Factor WASp Provides a Therapeutic Approach for Hematopoietic Malignancies.” Nature Communications 12 (1): 5581. doi:10.1038/s41467-021-25842-7.